Allurion Technologies

Allurion Technologies company information, Employees & Contact Information

Allurion was founded in 2009 with one mission: end obesity. The Allurion Program combines medical, digital, and nutritional approaches and engages an entire team to jumpstart weight loss and form lifelong healthy habits. Allurion has already helped thousands of people around the world lose weight, develop lifelong healthy habits, and transform their lives, with over 100,000 balloons placed, and over 1,000,000kg lost worldwide.

Company Details

Employees
194
Founded
-
Address
14 Huron Drive, Natick,ma 01760,united States
Phone
6178495552
Email
in****@****ion.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Natick, MA
Looking for a particular Allurion Technologies employee's phone or email?

Allurion Technologies Questions

News

Allurion Announces New Publications on Long-Term Weight Loss Results with the Allurion Program - Yahoo Finance

Allurion Announces New Publications on Long-Term Weight Loss Results with the Allurion Program Yahoo Finance

Allurion Announces New Strategic Direction With Increasing Focus on Low-Dose GLP-1 Combination Therapy, Muscle Mass Maintenance, and US Market Entry - Business Wire

Allurion Announces New Strategic Direction With Increasing Focus on Low-Dose GLP-1 Combination Therapy, Muscle Mass Maintenance, and US Market Entry Business Wire

Earnings call transcript: Allurion Technologies Q2 2025 sees strategy shift - Investing.com

Earnings call transcript: Allurion Technologies Q2 2025 sees strategy shift Investing.com

Allurion Announces Strategic Distribution Partnership with Minogue Medical in Canada to Pioneer New Approach Focused on Metabolically Healthy Weight Loss - Yahoo Finance

Allurion Announces Strategic Distribution Partnership with Minogue Medical in Canada to Pioneer New Approach Focused on Metabolically Healthy Weight Loss Yahoo Finance

Allurion Reports Second Quarter 2025 Financial Results and Provides Business Update - The Globe and Mail

Allurion Reports Second Quarter 2025 Financial Results and Provides Business Update The Globe and Mail

Earnings call transcript: Allurion Technologies Q1 2025 sees revenue drop, stock surges - Investing.com

Earnings call transcript: Allurion Technologies Q1 2025 sees revenue drop, stock surges Investing.com

Allurion to Report Second Quarter 2025 Financial Results on August 13, 2025 - Yahoo Finance

Allurion to Report Second Quarter 2025 Financial Results on August 13, 2025 Yahoo Finance

Allurion Appoints Adrian Wild as Senior Vice President, International Commercial - citybiz

Allurion Appoints Adrian Wild as Senior Vice President, International Commercial citybiz

Allurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs - Investopedia

Allurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs Investopedia

Allurion Announces Submission of PMA to FDA and Additional Analyses From Pivotal AUDACITY Study That Meet Both Endpoints - Yahoo Finance

Allurion Announces Submission of PMA to FDA and Additional Analyses From Pivotal AUDACITY Study That Meet Both Endpoints Yahoo Finance

Allurion Appoints Douglas Hudson to Board of Directors - citybiz

Allurion Appoints Douglas Hudson to Board of Directors citybiz

Allurion Reports First Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance

Allurion Reports First Quarter 2025 Financial Results and Provides Business Update Yahoo Finance

Allurion Debuts as a Publicly Traded Company on the NYSE - Business Wire

Allurion Debuts as a Publicly Traded Company on the NYSE Business Wire

Brendan Gibbons Appointed Chief Legal Officer at Allurion Technologies - citybiz

Brendan Gibbons Appointed Chief Legal Officer at Allurion Technologies citybiz

Allurion Receives Approval to Launch in Brazil - Business Wire

Allurion Receives Approval to Launch in Brazil Business Wire

Allurion Announces Collaboration Agreement with Medtronic to Expand Access to AI-Powered Weight Loss Program - Business Wire

Allurion Announces Collaboration Agreement with Medtronic to Expand Access to AI-Powered Weight Loss Program Business Wire

Allurion, a Global Leader in Weight Loss Technology, to Become Publicly Listed Through Business Combination With Compute Health Acquisition Corp. - Business Wire

Allurion, a Global Leader in Weight Loss Technology, to Become Publicly Listed Through Business Combination With Compute Health Acquisition Corp. Business Wire

Allurion Technologies, Inc. (ALUR) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance

Allurion Technologies, Inc. (ALUR) Reports Q2 Loss, Misses Revenue Estimates Yahoo Finance

Compute Health Acquisition Corp. Stockholders Approve Business Combination with Allurion - Business Wire

Compute Health Acquisition Corp. Stockholders Approve Business Combination with Allurion Business Wire

What Is Allurion Balloon For Weight Loss? Know The Side Effects, Cost - TODAY.com

What Is Allurion Balloon For Weight Loss? Know The Side Effects, Cost TODAY.com

Allurion Announces Appointment of MIT Distinguished Professor for AI and Health and MacArthur “Genius” Fellow Regina Barzilay, Ph.D. to Scientific Advisory Board - Business Wire

Allurion Announces Appointment of MIT Distinguished Professor for AI and Health and MacArthur “Genius” Fellow Regina Barzilay, Ph.D. to Scientific Advisory Board Business Wire

Medtronic will distribute Allurion’s swallowable weight-loss balloon - MedTech Dive

Medtronic will distribute Allurion’s swallowable weight-loss balloon MedTech Dive

Allurion cleared to resume sale of swallowable gastric balloon in France - BioWorld MedTech

Allurion cleared to resume sale of swallowable gastric balloon in France BioWorld MedTech

Curb your appetite with a holistic weight-loss approach - The Times

Curb your appetite with a holistic weight-loss approach The Times

ROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York City - Yahoo Finance

ROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York City Yahoo Finance

Medtronic signs on to distribute Allurion's swallowable balloon, AI platform for weight loss - Fierce Biotech

Medtronic signs on to distribute Allurion's swallowable balloon, AI platform for weight loss Fierce Biotech

Medtronic, Allurion partner on AI-based weight loss tech - MassDevice

Medtronic, Allurion partner on AI-based weight loss tech MassDevice

Allurion pulls weight loss balloon from the French market - MassDevice

Allurion pulls weight loss balloon from the French market MassDevice

ROTH to Host 3rd Annual Healthcare Opportunities Conference on October 9 in New York City - Yahoo Finance

ROTH to Host 3rd Annual Healthcare Opportunities Conference on October 9 in New York City Yahoo Finance

ALUR Stock Price and Chart — NYSE:ALUR - TradingView

ALUR Stock Price and Chart — NYSE:ALUR TradingView

Allurion Technologies: Study Results Cause Rally, But I'm Awaiting 2024 FDA Catalyst - Seeking Alpha

Allurion Technologies: Study Results Cause Rally, But I'm Awaiting 2024 FDA Catalyst Seeking Alpha

Medtimo files patent infringement complaint against Allurion Technologies - Med-Tech Insights

Medtimo files patent infringement complaint against Allurion Technologies Med-Tech Insights

Take Care Before Jumping Onto Allurion Technologies Inc. (NYSE:ALUR) Even Though It's 42% Cheaper - simplywall.st

Take Care Before Jumping Onto Allurion Technologies Inc. (NYSE:ALUR) Even Though It's 42% Cheaper simplywall.st

Weight loss balloon maker Allurion goes public on NYSE through SPAC merger - MassDevice

Weight loss balloon maker Allurion goes public on NYSE through SPAC merger MassDevice

Allurion’s swallowable gastric balloon introduced into the UK NHS - BioWorld MedTech

Allurion’s swallowable gastric balloon introduced into the UK NHS BioWorld MedTech

Allurion could face NYSE delisting - MassDevice

Allurion could face NYSE delisting MassDevice

Allurion nets $34M to market its swallowable weight-loss balloon - Fierce Biotech

Allurion nets $34M to market its swallowable weight-loss balloon Fierce Biotech

Woman loses 3 stone in 12 weeks without surgery - 'I'm excited about my future' - Daily Express

Woman loses 3 stone in 12 weeks without surgery - 'I'm excited about my future' Daily Express

Medtimo Files Patent Infringement Complaint Against Allurion Technologies - The Manila Times

Medtimo Files Patent Infringement Complaint Against Allurion Technologies The Manila Times

Allurion Technologies Raises $34 Million In Funding - Pulse 2.0

Allurion Technologies Raises $34 Million In Funding Pulse 2.0

Allurion launches pivotal US Elipse gastric balloon trial - MassDevice

Allurion launches pivotal US Elipse gastric balloon trial MassDevice

Allurion Technologies Raises $34M in Funding - FinSMEs

Allurion Technologies Raises $34M in Funding FinSMEs

The weight-loss balloon swallowed like a pill to avoid surgery - Daily Mail

The weight-loss balloon swallowed like a pill to avoid surgery Daily Mail

Top Allurion Technologies Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant